Serum Biomarkers for Portal Hypertension in Cirrhosis (Pan-CHESS1802)
Condition(s):Hypertension, PortalLast Updated:August 17, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Hypertension, PortalLast Updated:August 17, 2021Unknown status
Condition(s):Asthma; BiomarkersLast Updated:May 8, 2020Completed
Condition(s):Gastric CancerLast Updated:March 12, 2024Not yet recruiting
Condition(s):Localization-Related (Focal) (Partial) Idiopathic Epilepsy and Epileptic Syndromes With Seizures of Localized Onset; TRAIL: Tumor Necrosis Factor Related Apoptosis Inducing Ligand MCP-2; MCP-2: Monocyte Chemo-attractant Protein-2Last Updated:October 7, 2022Not yet recruiting
Condition(s):Chronic Airflow ObstructionLast Updated:May 13, 2011Unknown status
Condition(s):Gestational DiabetesLast Updated:June 1, 2022Completed
Condition(s):Postoperative Cognitive DysfunctionLast Updated:July 7, 2020Unknown status
Condition(s):Premature Ovarian Insufficiency; Diminished Ovarian Reserve; Biomarker; Copper; Ceruloplasmin; AgingLast Updated:October 26, 2023Recruiting
Condition(s):DeliriumLast Updated:October 3, 2023Recruiting
Condition(s):Major Depressive DisorderLast Updated:August 28, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.